Login
Toggle navigation
Videos
Categories
Trending
Ben McMillan, CIO of IDX Digital Assets, discusses this week's crypto market volatility and its potential implications.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Ben McMillan, CIO of IDX Digital Assets,
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Indian Equity Markets: Resilience and Strategic Outlook | Nimesh Shah, CEO , ICICI Prudential Mutual Fund .
00:10:00
Cal Everett Discusses Liberty Gold's Exciting Black Pine Discovery at One-to-One Mining Investment Conference
00:10:00
The Role of Cobalt in EV Battery Production and Market Dynamics
00:10:00
Addressing Capital Access Challenges in Today's Economic Landscape | David Solomon, CEO, Goldman Sachs.
00:10:00
Wojciech Kowalczyk, CEO of Boryszew SA, provides insights on the company's performance in 2023, including specific financial results.|Wojciech Kowalczyk, CEO of Boryszew SA,
00:10:00
Retirement Ready: Navigating the Transition with Erik Fromm | Erik Fromm - Financial Advisor, CSG Capital Partners of Janney Montgomery Scott, LLC
00:10:00
Navigating a Bear Market: Insights from Allodium Investment Consultants
00:10:00
We take an operators approach to investing|Gareth Jones, Managing Partner,FinTech Collective
00:10:00
Renewable Energy Development in Poland | Georg Hotar, CEO , Photon Energy NV .
00:10:00
Navigating the Early Retirement Gap: Key Considerations and Strategies
00:10:00
Innovative Volume Rendering Solutions by Singular Health: Transforming Medical Imaging | Thomas Hanly, CEO , Singular Health Group Ltd.
00:10:00
Tom Williams on Downing Renewables & Infrastructure Trust: Q1 Performance and Swedish Market Developments | Tom William, Manager, Downing Renewables and Infrastructure Trust PLC.